
Breakthrough research
Thus, making it possible to detect Alzheimer’s even a decade before the first symptoms appear.
Intriguing new research may make it easier to detect Alzheimer’s in its very earliest stages. This degenerative neurological disease affects more than 5 million Americans. Now a chance of detection perhaps even a decade before the first symptoms of memory loss and confusion appear. We still don’t have a cure for the disease, so catching it in the early, pre-dementia stages is imperative. Early detection could be the key to keeping your brain as strong as possible for as long as possible.
Early detection
“There is a reason early detection of Alzheimer’s is so important, says Elise Caccappolo, PhD, associate professor of neuropsychology. Undoubtedly, because most of the available treatments right now are more effective at the earliest stages in the disease process. In addition, there are also many lifestyle changes to make such as exercising more, eating a healthy diet, and continuing to learn new skills. Things that can push symptoms further down the road.” And when we do finally have a cure, Caccappolo adds, it will likely be most effective on patients who are not yet in the later stages of the disease.
Three new tests that may give patients a head start on battling the disease:
A New Eye Test
A growing body of research suggests that peepers could help reveal Alzheimer’s risk earlier. Researchers from Boston Medical Center took eye fluid from 80 patients who’d undergone eye surgery. What was found that those with cognitive impairment had lower levels of two proteins considered to be biomarkers for Alzheimer’s disease. This bolsters previous studies that found certain changes to retinal blood vessels to be associated with cognition and memory problems. The next step? Researchers hope to do additional clinical trials that incorporate neurological testing as well.
Virtual reality (VR) goggles may have a much more important function than entertaining teenagers. One of the first regions of the brain to be affected by Alzheimer’s is the entorhinal cortex, which is basically the body’s internal navigation system. This is why one of the first warning signs of Alzheimer’s is when a patient gets lost easily, even in familiar places. 45 patients with mild cognitive impairment were asked to complete a VR exercise. They had to walk through a simulated environment to complete a task. Those who had biomarkers for Alzheimer’s performed worse on the test than those who had MCI due to some other factor, such as aging or stress. Basically, demonstrating that the high-tech gadget may someday be used to identify early Alzheimer’s without requiring invasive tests.
Several new blood tests are in development that may spot markers for Alzheimer’s up to a decade before symptoms appear. One test looks at fats in the bloodstream, and another looks at proteins. Surprisingly, in trials, both were able to predict the onset of Alzheimer’s within 1 to 3 years with up to 90% accuracy. This newest blood test looks at a brain protein called IRS-1 and is commonly defective in people with the disease.
Researchers from the National Institute on Aging gathered samples from 174 people with Alzheimer’s. Those, along with 20 people who had diabetes and a group of 84 healthy people were tested. Those with Alzheimer’s had higher amounts of the inactive form of IRS-1 and lower amounts of the active form than those adults who were healthy. The blood test is still in development, but the researchers said the results were clear-cut. Additionally, they predict it will eventually be able to diagnose early Alzheimer’s with 100 percent accuracy.
By & Prevention Magazine
Discover more from TUTORING YOU
Subscribe to get the latest posts sent to your email.
